Clinical Trial Update: LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 trial update for LAM-001 in lung transplant recipients with bronchiolitis obliterans syndrome and chronic lung allograft dysfunction. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome
• Lung Allograft Dysfunction

Drugs mentioned

• LAM-001

Snippet

Sponsor: Steven Hays, MD | Conditions: Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction | Phase 2 | Status: RECRUITING